Table 2.
LGE data in asymptomatic and symptomatic DMD carriers
| Patient | LGE | LGEq (ml) | LGE (%) |
|---|---|---|---|
| Asymptomatic |
|
|
|
| 1 |
- |
0 |
0 |
| 2 |
- |
0 |
0 |
| 3 |
- |
0 |
0 |
| 4 |
- |
0 |
0 |
| 5 |
+ sepi |
2 |
2 |
| 6 |
+ mid/sepi |
3 |
2,6 |
| 7 |
- |
0 |
0 |
| 8 |
- |
0 |
0 |
| 9 |
- |
0 |
0 |
| 10 |
- |
0 |
0 |
| 11 |
- |
0 |
0 |
| 12 |
- |
0 |
0 |
| 13 |
- |
0 |
0 |
| 14 |
- |
0 |
0 |
| 15 |
+ mid |
2 |
1,6 |
| 16 |
+ sepi |
2 |
2 |
| 17 |
+ sepi |
2 |
1,6 |
| 18 |
+ sepi |
2 |
1,6 |
| 19 |
+ sepi |
1 |
1 |
| 20 |
+ mid/sepi |
2 |
2 |
| 21 |
- |
0 |
0 |
| Symptomatic |
|
|
|
| 1 |
+ mid/sepi |
1 |
1 |
| 2 |
- |
0 |
0 |
| 3 |
+ mid |
2 |
2,3 |
| 4 |
+ sepi |
3 |
3 |
| 5 |
- |
0 |
0 |
| 6 |
+ mid |
4 |
4 |
| 7 |
+ mid/sepi |
3 |
3 |
| 8 |
- |
0 |
0 |
| 9 | + mid/sepi | 3,5 | 3,5 |
LGE = late gadolinium enhancement; LGEq (mls) = LGE quantity (milliliters); LGE (%) = LGE percent; + = positive; − = negative; sepi = sub-epicardial; mid = mid-myocardial.